M.D.C. Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

M.D.C. Holdings wird ein jährliches Gewinn- und Umsatzwachstum von 8% bzw. 6.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 7.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 13% betragen.

Wichtige Informationen

8.0%

Wachstumsrate der Gewinne

7.2%

EPS-Wachstumsrate

Consumer Durables Gewinnwachstum	8.7%
Wachstumsrate der Einnahmen	6.6%
Zukünftige Eigenkapitalrendite	13.0%
Analystenabdeckung	Low
Zuletzt aktualisiert	19 Apr 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

M.D.C. Holdings, Inc.'s (NYSE:MDC) Intrinsic Value Is Potentially 24% Below Its Share Price

Sep 22

M.D.C. Holdings: Awaiting Q3 Results To Validate If Earnings Normalization Phase Has Started

Sep 06

We Think M.D.C. Holdings (NYSE:MDC) Can Stay On Top Of Its Debt

Sep 05

Upgrade: Analysts Just Made A Substantial Increase To Their M.D.C. Holdings, Inc. (NYSE:MDC) Forecasts

Aug 01

Is Now An Opportune Moment To Examine M.D.C. Holdings, Inc. (NYSE:MDC)?

Jul 28

We Like These Underlying Return On Capital Trends At M.D.C. Holdings (NYSE:MDC)

Jul 13

M.D.C. Holdings: Not The Best Financially But Has A Margin Of Safety

Jul 09

Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

Jun 05

M.D.C. Holdings: Trends Are Turning, But Better To Wait And See

May 26

M.D.C. Holdings' (NYSE:MDC) Dividend Will Be $0.50

Apr 21

When Should You Buy M.D.C. Holdings, Inc. (NYSE:MDC)?

Apr 14

Returns on Capital Paint A Bright Future For M.D.C. Holdings (NYSE:MDC)

Mar 30

Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

Mar 07

M.D.C. Holdings: Near-Term Concerns May Weigh On Share Price Performance

Feb 08

M.D.C. Q4 2022 Earnings Preview

Jan 30

M.D.C. Holdings (NYSE:MDC) Will Pay A Dividend Of $0.50

Jan 28

M.D.C. Holdings declares $0.50 dividend

Jan 24

M.D.C. Holdings, Inc. (NYSE:MDC) Shares Could Be 24% Above Their Intrinsic Value Estimate

Jan 13

Is M.D.C. Holdings, Inc. (NYSE:MDC) Potentially Undervalued?

Dec 29

Returns On Capital Are A Standout For M.D.C. Holdings (NYSE:MDC)

Dec 13

Gewinn- und Umsatzwachstumsprognosen

NYSE:MDC - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	5,672	502	269	294	1
12/31/2025	5,304	476	222	247	1
12/31/2024	4,885	423	289	314	3
12/31/2023	4,643	399	518	562	N/A
9/30/2023	4,816	359	1,162	1,185	N/A
6/30/2023	5,147	396	1,361	1,387	N/A
3/31/2023	5,498	492	1,186	1,214	N/A
12/31/2022	5,718	559	877	906	N/A
9/30/2022	5,664	642	194	222	N/A
6/30/2022	5,523	643	-79	-49	N/A
3/31/2022	5,437	608	-63	-32	N/A
12/31/2021	5,255	571	-238	-208	N/A
9/30/2021	5,014	555	-168	-139	N/A
6/30/2021	4,750	509	-94	-67	N/A
3/31/2021	4,269	439	-70	-44	N/A
12/31/2020	3,901	365	-50	-23	N/A
9/30/2020	3,781	311	95	120	N/A
6/30/2020	3,516	263	34	58	N/A
3/31/2020	3,348	233	-59	-34	N/A
12/31/2019	3,293	237	33	58	N/A
9/30/2019	3,071	199	-9	18	N/A
6/30/2019	3,084	202	76	104	N/A
3/31/2019	3,103	211	81	108	N/A
12/31/2018	3,065	210	-35	-8	N/A
9/30/2018	2,907	180	-83	-63	N/A
6/30/2018	2,726	187	-122	-108	N/A
3/31/2018	2,623	158	-93	-85	N/A
12/31/2017	2,578	141	68	71	N/A
9/30/2017	2,587	157	N/A	199	N/A
6/30/2017	2,580	122	N/A	260	N/A
3/31/2017	2,501	115	N/A	225	N/A
12/31/2016	2,327	103	N/A	116	N/A
9/30/2016	2,176	85	N/A	18	N/A
6/30/2016	2,048	74	N/A	-66	N/A
3/31/2016	1,932	67	N/A	-30	N/A
12/31/2015	1,909	66	N/A	0	N/A
9/30/2015	1,836	58	N/A	-17	N/A
6/30/2015	1,786	58	N/A	-23	N/A
3/31/2015	1,755	60	N/A	-34	N/A
12/31/2014	1,698	63	N/A	-164	N/A
9/30/2014	1,661	77	N/A	-217	N/A
6/30/2014	1,691	97	N/A	-220	N/A
3/31/2014	1,664	299	N/A	-328	N/A
12/31/2013	1,680	309	N/A	-270	N/A
9/30/2013	1,614	310	N/A	-284	N/A
6/30/2013	1,500	294	N/A	-239	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: MDCDas prognostizierte Gewinnwachstum (8% pro Jahr) liegt über der Sparquote (2.3%).

Ertrag vs. Markt: MDCDie Erträge des Unternehmens (8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.7% pro Jahr).

Hohe Wachstumserträge: MDCDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: MDCDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.4% pro Jahr).

Hohe Wachstumseinnahmen: MDCDie Einnahmen des Unternehmens (6.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: MDCDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (13 %).

M.D.C. Holdings Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 9.3% to US$55.00

Consensus revenue estimates increase by 13%

Price target increased by 18% to US$48.88

M.D.C. Holdings, Inc. Provides Operating Guidance for the Third Quarter and Full Year of 2023

Price target increased by 18% to US$41.38

Consensus EPS estimates increase by 37%

Recent updates

M.D.C. Holdings, Inc. Files Form 15

M.D.C. Holdings, Inc. Files Form 15

SH Residential Holdings, LLC completed the acquisition of M.D.C. Holdings, Inc. (NYSE:MDC) from a group of shareholders.

SH Residential Holdings, LLC completed the acquisition of M.D.C. Holdings, Inc. (NYSE:MDC) from a group of shareholders.

Independent Director recently sold US$389k worth of stock

Kaskela Law LLC Announces Shareholder Complaint Filed Against M.D.C. Holdings, Inc. (MDC) and Encourages Investors to Contact the Firm

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of US$0.55 per share at 3.5% yield

Third quarter dividend of US$0.55 announced

SH Residential Holdings, LLC entered into a definitive agreement to acquire M.D.C. Holdings, Inc. (NYSE:MDC) from a group of shareholders for $4.9 billion.

Investor sentiment improves as stock rises 16%

Price target increased by 9.3% to US$55.00

Sekisui House, Ltd. (TSE:1928) entered into a definitive agreement to acquire M.D.C. Holdings, Inc. (NYSE:MDC) from BlackRock, Inc. (NYSE:BLK), The Vanguard Group, Inc., Dimensional Fund Advisors LP, Larry Mizel, David Mandarich and others for $4.7 billion.

M.D.C. Sells To Sekisui At An Attractive Price; Further Upside Is Unlikely

Sekisui House, Ltd. (TSE:1928) entered into a definitive agreement to acquire M.D.C. Holdings, Inc. (NYSE:MDC) from BlackRock, Inc. (NYSE:BLK), The Vanguard Group, Inc., Dimensional Fund Advisors LP, Larry Mizel, David Mandarich and others for $4.7 billion.

Earnings Working Against M.D.C. Holdings, Inc.'s (NYSE:MDC) Share Price

We Think M.D.C. Holdings (NYSE:MDC) Can Stay On Top Of Its Debt

Returns On Capital At M.D.C. Holdings (NYSE:MDC) Have Hit The Brakes

M.D.C. Holdings: Navigating Through A Tough Housing Market

Investor sentiment improves as stock rises 17%

Is Now An Opportune Moment To Examine M.D.C. Holdings, Inc. (NYSE:MDC)?

Upcoming dividend of US$0.55 per share at 5.9% yield

Third quarter 2023 earnings released: EPS: US$1.45 (vs US$2.03 in 3Q 2022)

M.D.C. Holdings, Inc. Declares Quarterly Cash Dividend, Payable on November 22, 2023

M.D.C. Holdings, Inc. to Report Q3, 2023 Results on Oct 26, 2023

M.D.C. Holdings, Inc.'s (NYSE:MDC) Intrinsic Value Is Potentially 24% Below Its Share Price

M.D.C. Holdings: Awaiting Q3 Results To Validate If Earnings Normalization Phase Has Started

We Think M.D.C. Holdings (NYSE:MDC) Can Stay On Top Of Its Debt

Consensus revenue estimates increase by 13%

Upgrade: Analysts Just Made A Substantial Increase To Their M.D.C. Holdings, Inc. (NYSE:MDC) Forecasts

Upcoming dividend of US$0.55 per share at 4.3% yield

Price target increased by 18% to US$48.88

Senior VP & CFO exercised options and sold US$566k worth of stock

Independent Director recently sold US$284k worth of stock

M.D.C. Holdings, Inc. Provides Operating Guidance for the Third Quarter and Full Year of 2023

Is Now An Opportune Moment To Examine M.D.C. Holdings, Inc. (NYSE:MDC)?

New minor risk - Earnings quality

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Price target increased by 18% to US$41.38

We Like These Underlying Return On Capital Trends At M.D.C. Holdings (NYSE:MDC)

M.D.C. Holdings: Not The Best Financially But Has A Margin Of Safety

M.D.C. Holdings, Inc. to Report Q2, 2023 Results on Jul 27, 2023

M.D.C. Holdings, Inc.(NYSE:MDC) dropped from Russell Small Cap Comp Growth Index

Executive Chairman exercised options and sold US$30m worth of stock

Independent Director recently sold US$428k worth of stock

Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

M.D.C. Holdings: Trends Are Turning, But Better To Wait And See

Independent Director notifies of intention to sell stock

Consensus EPS estimates increase by 37%

President recently sold US$6.5m worth of stock

Price target increased by 7.1% to US$35.17

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of US$0.50 per share at 4.9% yield

M.D.C. Holdings' (NYSE:MDC) Dividend Will Be $0.50

When Should You Buy M.D.C. Holdings, Inc. (NYSE:MDC)?

Returns on Capital Paint A Bright Future For M.D.C. Holdings (NYSE:MDC)

Independent Lead Director recently sold US$302k worth of stock

Independent Lead Director notifies of intention to sell stock

Does M.D.C. Holdings (NYSE:MDC) Have A Healthy Balance Sheet?

Independent Director recently sold US$170k worth of stock

Independent Director recently sold US$115k worth of stock

M.D.C. Holdings: Near-Term Concerns May Weigh On Share Price Performance

Consensus EPS estimates fall by 18%, revenue upgraded

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of US$0.50 per share at 5.4% yield

M.D.C. Q4 2022 Earnings Preview

M.D.C. Holdings (NYSE:MDC) Will Pay A Dividend Of $0.50

M.D.C. Holdings, Inc. Announces Executive Changes

M.D.C. Holdings, Inc. Declares Quarterly Cash Dividend, Payable on February 22, 2023